These results suggest that prostate cancer cells expressing a low level of SFMBT2 may promote the infiltration of preadipocytes and TAMs by up-regulation of chemokines including CXCL8, CCL2, CXCL10, and CCL20. Here, CCL20 is linked to prostate cancer.